AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24918372 — intervention group
Group type: COMPARATOR
Intervention: Control (education on sleep hygiene and healthy lifestyle)
Number of subjects: 281
Study 21762937 — intervention group
Group type: EXPERIMENTAL
Intervention: CorCap cardiac support device
Number of subjects: 107
Study 21762937 — intervention group
Group type: COMPARATOR
Intervention: Optimal medical therapy alone
Number of subjects: 107
Study 20525984 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging (MRI)
Number of subjects: 150
Study 20525984 — intervention group
Group type: COMPARATOR
Intervention: Standard Echocardiography (Standard Echo)
Number of subjects: 150
Study 20525984 — intervention group
Group type: COMPARATOR
Intervention: Contrast Echocardiography (Contrast Echo)
Number of subjects: 150
Study 20525984 — intervention group
Group type: COMPARATOR
Intervention: Single-Photon Emission Computed Tomography (SPECT)
Number of subjects: 150
Study 17956932 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led parent-training program (12 sessions of Webster-Stratton Incredible Years)
Number of subjects: 117
Study 17956932 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychologist-led parent-training program (12 sessions of Webster-Stratton Incredible Years)
Number of subjects: 117
Study 17956932 — intervention group
Group type: COMPARATOR
Intervention: Minimal intervention (companion book only)
Number of subjects: 117
Study 17956932 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led treatment (after 7 sessions)
Number of subjects: 117
Study 17956932 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led treatment (after 9 sessions)
Number of subjects: 117
Study 17689171 — intervention group
Group type: EXPERIMENTAL
Intervention: Kneeling beside the manikin on the floor (F)
Number of subjects: 18
Study 17689171 — intervention group
Group type: EXPERIMENTAL
Intervention: Standing beside the manikin on a Table 37 cm in height (L)
Number of subjects: 18
Study 17689171 — intervention group
Group type: EXPERIMENTAL
Intervention: Standing beside the manikin on a Table 63 cm in height (H)
Number of subjects: 18
Study 15466678 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathways case management intervention
Number of subjects: 329
Study 15466678 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 329
Study 11722719 — intervention group
Group type: EXPERIMENTAL
Intervention: Galloy (palladium-free gallium-based alloy)
Number of subjects: 10
Study 11722719 — intervention group
Group type: COMPARATOR
Intervention: Permite C (high-copper amalgam)
Number of subjects: 10
Study 9223882 — intervention group
Group type: COMPARATOR
Intervention: Isotonic beverage 250 ml or apple juice 250 ml (Control group)
Number of subjects: 40
Study 9223882 — intervention group
Group type: EXPERIMENTAL
Intervention: Two slices of bread with isotonic beverage or apple juice (Breakfast group)
Number of subjects: 40
Study 8260372 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential ifosfamide/carboplatin
Number of subjects: 152
Study 8260372 — intervention group
Group type: COMPARATOR
Intervention: Single agent carboplatin
Number of subjects: 152
Study 3314458 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem (90 mg twice daily)
Number of subjects: 27
Study 3314458 — intervention group
Group type: COMPARATOR
Intervention: Atenolol (50 mg once daily)
Number of subjects: 27
Study 30697986 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone hydrochloride
Number of subjects: 0
Study 27755654 — intervention group
Group type: EXPERIMENTAL
Intervention: Complicated Grief Treatment (CGT)
Number of subjects: 69
Study 27755654 — intervention group
Group type: COMPARATOR
Intervention: Interpersonal Psychotherapy (Control)
Number of subjects: 69
Study 24974864 — intervention group
Group type: COMPARATOR
Intervention: Diluted Formocresol (FC)
Number of subjects: 60
Study 24974864 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium Hydroxide (CH)
Number of subjects: 60
Study 24974864 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Level Laser Therapy (LLLT)
Number of subjects: 60
Study 24974864 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium Hydroxide preceded by Low Level Laser Therapy (LLLT + CH)
Number of subjects: 60
Study 24067553 — intervention group
Group type: EXPERIMENTAL
Intervention: CYD-TDV (3 doses at 0, 6, and 12 months)
Number of subjects: 600
Study 24067553 — intervention group
Group type: COMPARATOR
Intervention: Placebo (first and second injection) and tetanus/diphtheria/acellular pertussis vaccine (third injection)
Number of subjects: 600
Study 21352597 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-year school-based lifestyle improvement program
Number of subjects: 38
Study 21352597 — intervention group
Group type: EXPERIMENTAL
Intervention: Health-promoter agents (university students) implementing nutritional and physical activity objectives
Number of subjects: 38
Study 21352597 — intervention group
Group type: COMPARATOR
Intervention: Control group following usual activities
Number of subjects: 38
Study 19755646 — intervention group
Group type: EXPERIMENTAL
Intervention: $5 cash with the initial mailing
Number of subjects: 6359
Study 19755646 — intervention group
Group type: EXPERIMENTAL
Intervention: $20 promise upon completion of the information form (for cases)
Number of subjects: 6359
Study 19755646 — intervention group
Group type: EXPERIMENTAL
Intervention: $10 promise upon completion of the baseline survey (for relatives)
Number of subjects: 6359
Study 19755646 — intervention group
Group type: COMPARATOR
Intervention: Registered mail
Number of subjects: 6359
Study 19755646 — intervention group
Group type: COMPARATOR
Intervention: First-class mail
Number of subjects: 6359
Study 16420574 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 ng kg(‐1) National Reference Endotoxin
Number of subjects: 20
Study 16420574 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 20
Study 15018698 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard education
Number of subjects: 40
Study 15018698 — intervention group
Group type: EXPERIMENTAL
Intervention: Further education (randomized group)
Number of subjects: 40
Study 15018698 — intervention group
Group type: COMPARATOR
Intervention: Baseline assessment
Number of subjects: 40
Study 11397724 — intervention group
Group type: EXPERIMENTAL
Intervention: 450 mL of black tea initially, followed by 900 mL daily for 4 weeks
Number of subjects: 49
Study 11397724 — intervention group
Group type: COMPARATOR
Intervention: Water consumed initially, followed by 900 mL daily for 4 weeks
Number of subjects: 49
Study 9415352 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate asthma education
Number of subjects: 125
Study 9415352 — intervention group
Group type: COMPARATOR
Intervention: Delayed asthma education (Control)
Number of subjects: 125
Study 9415352 — intervention group
Group type: EXPERIMENTAL
Intervention: Age over 60 years
Number of subjects: 125
Study 9415352 — intervention group
Group type: EXPERIMENTAL
Intervention: Age categories
Number of subjects: 125
Study 8424519 — intervention group
Group type: EXPERIMENTAL
Intervention: OTFC (7‐10 micrograms/kg)
Number of subjects: 38
Study 8424519 — intervention group
Group type: COMPARATOR
Intervention: Placebo identical in appearance to OTFC
Number of subjects: 38
Study 3631182 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracameral carbachol
Number of subjects: 44
Study 3631182 — intervention group
Group type: COMPARATOR
Intervention: Balanced salt solution (Control)
Number of subjects: 44
Study 30034230 — intervention group
Group type: EXPERIMENTAL
Intervention: TIO+OLO 5/5 μg
Number of subjects: 461
Study 30034230 — intervention group
Group type: COMPARATOR
Intervention: TIO 5 μg
Number of subjects: 461
Study 27173787 — intervention group
Group type: EXPERIMENTAL
Intervention: PR/simeprevir (triple) therapy
Number of subjects: 300
Study 27173787 — intervention group
Group type: COMPARATOR
Intervention: PR therapy
Number of subjects: 300
Study 24836914 — intervention group
Group type: EXPERIMENTAL
Intervention: Reading and language intervention (two 9-week blocks of daily intervention delivered by trained teaching assistants)
Number of subjects: 145
Study 24836914 — intervention group
Group type: COMPARATOR
Intervention: Typical classroom instruction (9 weeks) followed by intervention (9 weeks)
Number of subjects: 145
Study 22504121 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery rescripting of early memories
Number of subjects: 14
Study 22504121 — intervention group
Group type: COMPARATOR
Intervention: Reading task
Number of subjects: 14
Study 20368068 — intervention group
Group type: EXPERIMENTAL
Intervention: Lian propofol TCI system (6 microg/ml initial target plasma concentration)
Number of subjects: 90
Study 20368068 — intervention group
Group type: COMPARATOR
Intervention: Marsh system (control group)
Number of subjects: 90
Study 18060419 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave therapy (ESWT) without alendronate
Number of subjects: 48
Study 18060419 — intervention group
Group type: COMPARATOR
Intervention: Extracorporeal shockwave therapy (ESWT) with alendronate
Number of subjects: 48
Study 15807187 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse therapy (2 microg oral Alfacalcidol twice or thrice weekly)
Number of subjects: 158
Study 15807187 — intervention group
Group type: COMPARATOR
Intervention: Daily therapy (0.5 microg oral Alfacalcidol per day)
Number of subjects: 158
Study 15807187 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse therapy
Number of subjects: 158
Study 15807187 — intervention group
Group type: COMPARATOR
Intervention: Daily therapy
Number of subjects: 158
Study 15807187 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 158
Study 12211526 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous hematopoietic stem cell transplantation (HSCT) following high-dose chemotherapy
Number of subjects: 500
Study 10180718 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol inhaled from the piezoelectric device (PED)
Number of subjects: 0
Study 10180718 — intervention group
Group type: COMPARATOR
Intervention: Albuterol inhaled from the metered dose inhaler (MDI)
Number of subjects: 0
Study 8025985 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluosol
Number of subjects: 430
Study 2689147 — intervention group
Group type: EXPERIMENTAL
Intervention: Super Bond, a 4‐Meta‐PMMA resin
Number of subjects: 54
Study 2689147 — intervention group
Group type: EXPERIMENTAL
Intervention: ABC (Adhesive Bridge Cement)
Number of subjects: 54
Study 2689147 — intervention group
Group type: EXPERIMENTAL
Intervention: Microfill pontic, both composite adhesives
Number of subjects: 54
Study 2689147 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 54
Study 31722594 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberal RBC transfusion
Number of subjects: 0
Study 31722594 — intervention group
Group type: COMPARATOR
Intervention: Restrictive RBC transfusion
Number of subjects: 0
Study 30337921 — intervention group
Group type: EXPERIMENTAL
Intervention: HFA‐BDP metered‐dose inhaler (MDI) ETN (n = 11)
Number of subjects: 23
Study 30337921 — intervention group
Group type: COMPARATOR
Intervention: Placebo MDI ETN (n = 12)
Number of subjects: 23
Study 30337921 — intervention group
Group type: EXPERIMENTAL
Intervention: HFA‐BDP MDI ETN
Number of subjects: 23
Study 27562424 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocebo group (cognitive manipulation with sham inert cream)
Number of subjects: 30
Study 27562424 — intervention group
Group type: COMPARATOR
Intervention: Control group (cognitive manipulation with sham inert cream)
Number of subjects: 30
Study 25343395 — intervention group
Group type: EXPERIMENTAL
Intervention: 22,600 ppm F‐ varnish applied every six months
Number of subjects: 200
Study 25343395 — intervention group
Group type: COMPARATOR
Intervention: Placebo fluoride varnish applied every six months
Number of subjects: 200
Study 25343395 — intervention group
Group type: EXPERIMENTAL
Intervention: 22,600 ppm F‐ varnish
Number of subjects: 200
Study 25343395 — intervention group
Group type: COMPARATOR
Intervention: Placebo fluoride varnish
Number of subjects: 200
Study 21806617 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-mouth scaling and root planing (FMSRP)
Number of subjects: 34
Study 21806617 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial-mouth scaling and root planing (PMSRP)
Number of subjects: 34
Study 21806617 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 34
Study 20414547 — intervention group
Group type: EXPERIMENTAL
Intervention: Casein
Number of subjects: 0
Study 20414547 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein
Number of subjects: 0
Study 20414547 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy protein
Number of subjects: 0
Study 20414547 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 18347904 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (5 A Day for Better Health)
Number of subjects: 5
Study 16388329 — intervention group
Group type: EXPERIMENTAL
Intervention: HFE genotyping
Number of subjects: 121
Study 16388329 — intervention group
Group type: COMPARATOR
Intervention: Iron test (transferrin saturation measurement)
Number of subjects: 121
Study 16388329 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype group
Number of subjects: 121
Study 16388329 — intervention group
Group type: COMPARATOR
Intervention: Phenotype group
Number of subjects: 121
Study 16388329 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge assessment
Number of subjects: 121
Study 12032877 — intervention group
Group type: EXPERIMENTAL
Intervention: Efavirenz (EFV)
Number of subjects: 67
Study 12032877 — intervention group
Group type: COMPARATOR
Intervention: Nevirapine (NVP)
Number of subjects: 67
Study 10831472 — intervention group
Group type: EXPERIMENTAL
Intervention: Supraphysiologic doses of estradiol and progesterone for 8 weeks, followed by withdrawal of both steroids.
Number of subjects: 16
Study 9467248 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous load of hypertonic glucose solution
Number of subjects: 20
Study 9467248 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 individuals)
Number of subjects: 20
Study 1410028 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteotomy defect with 30% of cross-sectional area removed
Number of subjects: 50
Study 1410028 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteotomy defect with 37% of cross-sectional area removed
Number of subjects: 50
Study 1410028 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteotomy defect with 50% of cross-sectional area removed
Number of subjects: 50
Study 1410028 — intervention group
Group type: EXPERIMENTAL
Intervention: Beveled or rounded ends of osteotomy
Number of subjects: 50
Study 1410028 — intervention group
Group type: EXPERIMENTAL
Intervention: One-diameter length of bone removed
Number of subjects: 50
Study 1410028 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-diameter length of bone removed
Number of subjects: 50
Study 1410028 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-diameter length of bone removed
Number of subjects: 50
Study 1410028 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-diameter length of bone removed
Number of subjects: 50
Study 1410028 — intervention group
Group type: COMPARATOR
Intervention: Control group with no alteration to the bone
Number of subjects: 50
Study 2417434 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% dextran-60 as a plasma substitute
Number of subjects: 60
Study 2417434 — intervention group
Group type: COMPARATOR
Intervention: Microaggregate‐poor whole blood
Number of subjects: 60
Study 30485447 — intervention group
Group type: EXPERIMENTAL
Intervention: Cartilage tympanoplasty (CT)
Number of subjects: 0
Study 30485447 — intervention group
Group type: EXPERIMENTAL
Intervention: Cartilage tympanoplasty combined with eustachian tube balloon dilatation (ETBD+CT)
Number of subjects: 0
Study 30485447 — intervention group
Group type: COMPARATOR
Intervention: Eustachian tube balloon dilatation (ETBD)
Number of subjects: 0
Study 30485447 — intervention group
Group type: COMPARATOR
Intervention: Control group (conservative treatment)
Number of subjects: 0
Study 29550779 — intervention group
Group type: EXPERIMENTAL
Intervention: Body Brain Life-General Practice (BBL-GP)
Number of subjects: 240
Study 29550779 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle Modification Programme (LMP)
Number of subjects: 240
Study 29550779 — intervention group
Group type: COMPARATOR
Intervention: Email-only programme providing general health information
Number of subjects: 240
Study 26566669 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban 2.5 mg twice a day
Number of subjects: 0
Study 26566669 — intervention group
Group type: COMPARATOR
Intervention: Warfarin (adjusted-dose)
Number of subjects: 0
Study 23446086 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5% w/w diclofenac sodium in dimethyl sulfoxide
Number of subjects: 209
Study 23446086 — intervention group
Group type: COMPARATOR
Intervention: Control solutions containing no diclofenac
Number of subjects: 209
Study 23446086 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (active and control)
Number of subjects: 209
Study 22827167 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 240
Study 22827167 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study 20605255 — intervention group
Group type: EXPERIMENTAL
Intervention: Dutasteride 0.5 mg once daily for 6 months
Number of subjects: 153
Study 20605255 — intervention group
Group type: COMPARATOR
Intervention: Placebo once daily for 6 months
Number of subjects: 153
Study 17645387 — intervention group
Group type: EXPERIMENTAL
Intervention: Familiar live music during chemotherapy (20 minutes)
Number of subjects: 50
Study 17645387 — intervention group
Group type: COMPARATOR
Intervention: Standard chemotherapy
Number of subjects: 50
Study 16127039 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid 600 mg administered enterally
Number of subjects: 18
Study 16127039 — intervention group
Group type: COMPARATOR
Intervention: Linezolid 600 mg administered intravenously
Number of subjects: 18
Study 11700782 — intervention group
Group type: EXPERIMENTAL
Intervention: NK1 receptor antagonists
Number of subjects: 245
Study 9142794 — intervention group
Group type: COMPARATOR
Intervention: MMRV and placebo
Number of subjects: 812
Study 9142794 — intervention group
Group type: COMPARATOR
Intervention: MMRV, DTaP, and OPV
Number of subjects: 812
Study 9142794 — intervention group
Group type: COMPARATOR
Intervention: MMRV
Number of subjects: 812
Study 9142794 — intervention group
Group type: EXPERIMENTAL
Intervention: VARIVAX
Number of subjects: 812
Study 7974903 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined-modality approach with chemotherapy, radiation therapy, and surgery
Number of subjects: 0
Study 7974903 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytotoxic agents (bleomycin, methotrexate, cisplatin, 5-FU)
Number of subjects: 0
Study 7974903 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy
Number of subjects: 0
Study 7974903 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 3115419 — intervention group
Group type: EXPERIMENTAL
Intervention: Marathon running (no drugs)
Number of subjects: 47
Study 3115419 — intervention group
Group type: EXPERIMENTAL
Intervention: Marathon running (with drugs)
Number of subjects: 47
Study 3115419 — intervention group
Group type: COMPARATOR
Intervention: Walking 37 km for four consecutive days (healthy men)
Number of subjects: 47
Study 2125794 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA infusion
Number of subjects: 5
Study 2125794 — intervention group
Group type: COMPARATOR
Intervention: Normal saline infusion (Control)
Number of subjects: 5
Study 2125794 — intervention group
Group type: COMPARATOR
Intervention: Baseline (No infusion)
Number of subjects: 5
Study 807094 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula diets varying in protein and calorie content (100 or 175 kcal/kg and 1 or 4 g/kg)
Number of subjects: 38
Study 807094 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injection of 100,000 IU water-miscible vitamin A palmitate
Number of subjects: 38
Study 807094 — intervention group
Group type: EXPERIMENTAL
Intervention: Stabilization period with fluids, antibiotics, and increasing intake of protein and calories to 1 g protein and 100 kcal/kg
Number of subjects: 38
Study 31843425 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapist-led exercise interventions
Number of subjects: 30
Study 31843425 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic alliance during treatment
Number of subjects: 30
Study 31034032 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel plus aspirin (600 mg loading dose on day 1 followed by 75 mg daily for days 2-90)
Number of subjects: 4881
Study 31034032 — intervention group
Group type: COMPARATOR
Intervention: Aspirin alone (50 to 325 mg/d)
Number of subjects: 4881
Study 27013511 — intervention group
Group type: EXPERIMENTAL
Intervention: Varithena 1% (polidocanol endovenous microfoam)
Number of subjects: 77
Study 27013511 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 25577665 — intervention group
Group type: EXPERIMENTAL
Intervention: B. aristata/S. marianum 588/105 mg, 1 tablet during lunch and 1 tablet during dinner for six months
Number of subjects: 137
Study 25577665 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 137
Study 23358884 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac disease
Number of subjects: 2719
Study 23358884 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac disease in women
Number of subjects: 2719
Study 23358884 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac disease in men
Number of subjects: 2719
Study 22094764 — intervention group
Group type: EXPERIMENTAL
Intervention: Denervation group (surgical denervation by excision of 1 cm of thoracodorsal nerve)
Number of subjects: 28
Study 22094764 — intervention group
Group type: COMPARATOR
Intervention: Intact group (thoracodorsal nerve saved intact)
Number of subjects: 28
Study 19114153 — intervention group
Group type: EXPERIMENTAL
Intervention: Home Visitation Programme (HVP)
Number of subjects: 211
Study 19114153 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 211
Study 16763533 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloprost (28-day intravenous treatment)
Number of subjects: 200
Study 16763533 — intervention group
Group type: COMPARATOR
Intervention: Lumbar sympathectomy (LS)
Number of subjects: 200
Study 15049399 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aqueous nasal spray
Number of subjects: 0
Study 15049399 — intervention group
Group type: COMPARATOR
Intervention: Loratadine
Number of subjects: 0